Literature DB >> 31323348

Incidence of false-positive transmissions during remote rhythm monitoring with implantable loop recorders.

Muhammad R Afzal1, Julie Mease2, Tanner Koppert2, Toshimasa Okabe2, Jaret Tyler2, Mahmoud Houmsse2, Ralph S Augostini2, Raul Weiss2, John D Hummel2, Steven J Kalbfleisch2, Emile G Daoud2.   

Abstract

BACKGROUND: Implantable loop recorder (ILR) is preferred strategy for prolonged rhythm monitoring.
OBJECTIVE: The purpose of this study was to report the incidence and causes of false-positive (FP) diagnoses during remote monitoring with ILR.
METHODS: During a 4-week study period, all consecutive remote transmissions in patients with ILR (Reveal LINQ, Medtronic) implanted for atrial fibrillation (AF) surveillance, cryptogenic stroke (CS), and syncope were reviewed. A nurse specializing in device management and an electrophysiologist adjudicated all transmissions. Primary endpoint of the study was incidence of FP in patients with AF, CS, and syncope.
RESULTS: A total of 695 remote transmissions (scheduled downloads: 414; Alerts: 281) sent from 559 patients were adjudicated. The majority of patients had ILR for AF surveillance (n = 321), followed by CS (n =168) and syncope (n = 70) with nominal programming for rhythm diagnosis. Incidence of FP transmissions during the study period was 46%, 86%, and 71% in patients with AF, CS, and syncope, respectively. Incidence of FP transmissions was higher in patients with CS and syncope than in patients with AF (P <.001). For scheduled transmissions, primary causes of FP were signal dropout and undersensing; for alert transmissions, primary reasons for FP were premature atrial and ventricular ectopy.
CONCLUSION: Incidence of FP during remote monitoring with nominal settings on this ILR was substantial, ranging from 46% to 86% depending on the indication for implantation. Adjudication of these transmissions required a considerable time commitment from electrophysiologists and device clinic personnel but would be required to avoid misdiagnosis and potential errors in clinical management.
Copyright © 2019 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Cryptogenic stroke; Implantable loop recorder; Remote transmissions; Syncope

Mesh:

Year:  2019        PMID: 31323348     DOI: 10.1016/j.hrthm.2019.07.015

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  12 in total

1.  High Specificity Wearable Device With Photoplethysmography and Six-Lead Electrocardiography for Atrial Fibrillation Detection Challenged by Frequent Premature Contractions: DoubleCheck-AF.

Authors:  Justinas Bacevicius; Zygimantas Abramikas; Ernestas Dvinelis; Deimile Audzijoniene; Marija Petrylaite; Julija Marinskiene; Justina Staigyte; Albinas Karuzas; Vytautas Juknevicius; Rusne Jakaite; Viktorija Basyte-Bacevice; Neringa Bileisiene; Andrius Solosenko; Daivaras Sokas; Andrius Petrenas; Monika Butkuviene; Birute Paliakaite; Saulius Daukantas; Andrius Rapalis; Germanas Marinskis; Eugenijus Jasiunas; Angeliki Darma; Vaidotas Marozas; Audrius Aidietis
Journal:  Front Cardiovasc Med       Date:  2022-04-06

Review 2.  Subcutaneouscardiac Rhythm Monitors: A Comprehensive Review.

Authors:  Gaurav Aggarwal; Saurabh Aggarwal; Venkata Alla; Bharat Narasimhan; Kyungmoo Ryu; Courtney Jeffery; Dhanunjaya Lakkireddy
Journal:  J Atr Fibrillation       Date:  2021-02-28

3.  Analysis of the determining factors of detectable P-wave and amplitude of QRS complex sensed by implantable loop recorder.

Authors:  Jang Ho Ahn; Hyunho Ryu; Il-Young Oh; Youngjin Cho; Ji Hyun Lee
Journal:  J Arrhythm       Date:  2021-06-24

4.  Factors affecting signal quality in implantable cardiac monitors with long sensing vector.

Authors:  Giovanni B Forleo; Claudia Amellone; Riccardo Sacchi; Leonida Lombardi; Maria Teresa Lucciola; Valentina Scotti; Maurizio Viecca; Marco Schiavone; Daniele Giacopelli; Massimo Giammaria
Journal:  J Arrhythm       Date:  2021-06-21

5.  Neurologist-Led Management of Implantable Loop-Recorders After Embolic Stroke of Undetermined Source.

Authors:  Slaven Pikija; Cornelia Rösler; Ursula Leitner; Thomas Zellner; Nele Bubel; Bernhard Ganser; Constantin Hecker; Johannes Sebastian Mutzenbach
Journal:  Front Neurol       Date:  2022-01-28       Impact factor: 4.003

6.  Accuracy of arrhythmia detection in implantable cardiac monitors: A prospective randomized clinical trial comparing Reveal LINQ and Confirm Rx.

Authors:  John Ip; Brian Jaffe; Mark Castellani; Ali Sheikh; Carson Castellani; Randy Ip
Journal:  Pacing Clin Electrophysiol       Date:  2020-10-03       Impact factor: 1.976

7.  Quality of life and healthcare utilisation improvements after atrial fibrillation ablation.

Authors:  Dhiraj Gupta; Johan Vijgen; Tom De Potter; Daniel Scherr; Hugo Van Herendael; Sebastien Knecht; Richard Kobza; Benjamin Berte; Niels Sandgaard; Jean-Paul Albenque; Gábor Széplaki; Yorick Stevenhagen; Philippe Taghji; Matt Wright; Mattias Duytschaever
Journal:  Heart       Date:  2021-05-05       Impact factor: 5.994

8.  Clinical and electrophysiological predictors of device-detected new-onset atrial fibrillation during 3 years after cardiac surgery.

Authors:  Elham Bidar; Stef Zeemering; Martijn Gilbers; Aaron Isaacs; Sander Verheule; Matthias D Zink; Bart Maesen; Sander Bramer; Michal Kawczynski; Isabelle C Van Gelder; Harry J G M Crijns; Jos G Maessen; Ulrich Schotten
Journal:  Europace       Date:  2021-12-07       Impact factor: 5.486

9.  The BIOMONITOR III Injectable Cardiac Monitor: Clinical Experience with a Novel Injectable Cardiac Monitor.

Authors:  Nico Reinsch; Anna Füting; Dennis Höwel; Kars Neven
Journal:  J Clin Med       Date:  2022-03-16       Impact factor: 4.241

Review 10.  Current Advancement in Diagnosing Atrial Fibrillation by Utilizing Wearable Devices and Artificial Intelligence: A Review Study.

Authors:  Yu-Chiang Wang; Xiaobo Xu; Adrija Hajra; Samuel Apple; Amrin Kharawala; Gustavo Duarte; Wasla Liaqat; Yiwen Fu; Weijia Li; Yiyun Chen; Robert T Faillace
Journal:  Diagnostics (Basel)       Date:  2022-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.